Language Select
Varian Logo

Press Releases

June 14, 2018
Varian (NYSE: VAR) today announced it received notification from Sirtex Medical Limited (Sirtex) on June 14, 2018 that its board has determined that the proposal from CDH Investments and China... Read more
June 11, 2018
Varian (NYSE: VAR) today announced that it will report results for the third quarter of fiscal year 2018 after market close on Wednesday, July 25, 2018. The news release will be followed by a... Read more
June 05, 2018
Varian (NYSE: VAR) today announced it will be demonstrating its comprehensive portfolio of advanced brachytherapy solutions, June 7-9 in San Francisco, CA at the American Brachytherapy Society... Read more
May 30, 2018
Designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients, treatments with Varian's (NYSE: VAR) Halcyon™ system have... Read more
May 23, 2018
Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, and J. Michael Bruff, senior vice president of investor relations, will present at the Jefferies Global Healthcare... Read more
May 22, 2018
Varian (NYSE: VAR) today announced it received notice from Sirtex Medical Limited (Sirtex) on May 21, 2018 (Pacific daylight time) that the board of directors of Sirtex has now received a binding... Read more
May 17, 2018
Varian (NYSE: VAR) today announced it has signed a software technology training and education cooperation agreement with the Brazil Ministry of Health (MOH) and seven universities and science and... Read more
May 16, 2018
Varian (NYSE: VAR) announced two patients with brain cancer were the first patients in Korea to be treated using the company's HyperArc™ High Definition Radiotherapy (HDRT), a new type of... Read more
May 07, 2018
Varian (NYSE:VAR) today announced it has acquired Cooperative CL Enterprises (COOP), a leading distributor of radiotherapy equipment in Taiwan. COOP currently employs 45 people, and has... Read more
May 04, 2018
Varian (NYSE: VAR) today commented on the press release of Sirtex Medical Limited (Sirtex) dated May 4, 2018 announcing that Sirtex had received an unsolicited non-binding, indicative and... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]